Trending stocks today
The Panic-Proof Portfolio (Stockchase Research)
By Michael O'Reilly at Stockchase Premium
Member since: Jul '20 · 2835 Opinions
Rating Card
| All | 
Rating
| 
Big Win
| 
Win
| 
Neutral
| 
Loss
| 
Big Loss
|  |
|---|---|---|---|---|---|---|---|
| 5 | 904 22.72% | 977 24.55% | 568 14.27% | 943 23.70% | 587 14.75% | ||
| 1 Month | 5 | 111 9.12% | 419 34.43% | 303 24.90% | 361 29.66% | 23 1.89% | |
| 6 Months | 5 | 269 24.43% | 270 24.52% | 153 13.90% | 257 23.34% | 152 13.81% | |
| 12 Months | 5 | 284 29.22% | 195 20.06% | 67 6.89% | 208 21.40% | 218 22.43% | |
| 2 Years | 5 | 240 34.83% | 93 13.50% | 45 6.53% | 117 16.98% | 194 28.16% |
Stock Opinions by The Panic-Proof Portfolio (Stockchase Research)
$451.120
Unknown
The company is engaged in new iron ore, copper, and lithium projects worldwide -- looking to increase capital spending 33% to $9.5 billion. It trades at 9x earnings, 1.7x book and supports a 19% ROE. It pays a solid dividend, backed by a payout ratio under 67% of cash flow. We recommend setting a stop-loss at $49, looking to achieve $82 -- upside potential of 38%. Yield 7.3%
(Analysts’ price target is $82.20)EQNR engages in oil and gas exploration and marketing in the North Sea, focused on Norway. It also has a very active sustainability program, centred on wind farm renewables. It trades at 7x earnings, 1.3x book and supports a 20% ROE. It pays a robust dividend, backed by a payout ratio under 40% of cash flow. We recommend setting a stop-loss at $18, looking to achieve $28 -- upside potential of 24%. Yield 6.1%
(Analysts’ price target is $28.33)Our PAST TOP PICK with JXN has triggered its stop at $86. To remain disciplined, we recommend covering the position at this time. When combined with our previous guidance, this will result in a net investment gain of 93%.
Our PAST TOP PICK with RNR has triggered its stop at $253. To remain disciplined, we recommend covering the position at this time. When combined with our previous guidance, this will result in a net investment gain of 17%.
IMXI provides international online payment services to customers in North and South America, the Caribbean, Africa and Asia. Recently reported earnings modestly beat expectations and analysts expect a further 5% increase in EPS. The company has been prudently using some cash reserves to reduce debt and buy back shares. It trades at 12x earnings and supports a ROE of 40%. We recommend setting a stop-loss at $18, looking to achieve $26 -- upside potential of 19%. Yield 0%
(Analysts’ price target is $26.40)The consumer product monster has increased debt lately, but analysts feel comfortable with the low debt to earnings ratio. This is allowing the company to continue growing cash reserves. It trades at 24x earnings and supports a 20% ROE. We recommend setting a stop-loss at $133 looking to achieve $174 -- upside potential of 19%. Yield 3.3%
(Analysts’ price target is $174.28)The big pharma is developing a GLP-1 weight loss treatment that avoids injections -- a big game changer - and trials are looking good. The stock trades at 32x earnings and supports a 16% ROE. We recommend setting a stop-loss at $52, looking to achieve $88 -- upside potential of 30%. Yield 2.2%
(Analysts’ price target is $88.01)
The conglomerate managed by Warren Buffet is a good flight to safety. We like that cash reserves are growing, while debt is reduced and shares bought back, and it supports an 18% ROE -- solid management. We recommend setting a stop-loss at $400, looking to achieve $535 -- 18% upside. Yield 0%
(Analysts’ price target is $497.67)